Document is current
Any future updates will be listed below
-
Authors
Ferraro, Sara https://orcid.org/0000-0002-7549-1807
Cappello, Emiliano https://orcid.org/0000-0003-0386-3816
Fornili, Marco https://orcid.org/0000-0002-5713-3926
Convertino, Irma https://orcid.org/0000-0002-7883-3657
Bonaso, Marco https://orcid.org/0000-0001-8813-2902
Lucenteforte, Ersilia https://orcid.org/0000-0001-5608-5902
Tuccori, Marco https://orcid.org/0000-0002-7979-8486
- License Information
-
More Information
Article History
Accepted: 17 October 2024
First Online: 8 November 2024
Declarations
:
: No funding was received for the conduct of this study or the preparation of this article.
: Sara Ferraro, Emiliano Cappello, Marco Fornili, Irma Convertino, Marco Bonaso, Ersilia Lucenteforte have no conflicts of interest that are directly relevant to the content of this article. Marco Tuccori is an Editorial Board member of Drug Safety. Marco Tuccori was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: Ethics approval is not applicable because this is a disproportionality analysis using public data extracted from the European spontaneous reporting system (EudraVigilance).
: Not applicable.
: Not applicable.
: Data collected are available in EudraVigilance, the European database of suspected ADR reports, which includes public online access to suspected side-effect reports.
: Not applicable.
: Conceptualisation: MT, SF, IC, EC, MB. Methodology: MT, SF, IC. Formal analysis and investigation: MT, MF, SF, EL. Writing, original first draft preparation: SF. Writing, review and editing: SF, IC, EC, MB. Funding acquisition: none. Supervision: MT, EL. All authors interpreted the results. All authors read and approved the final version.
